CD4 and cancer: Additionally, anti-CD4 mAb + GST-CD4 exhibited a notable reversal of the expression of naive CD4 + T cells, epithelial-to-mesenchymal transition (EMT), and cancer-associated fibroblast (CAF) markers in mice treated with anti-CD4 mAb (Fig. 6C).